Severe kidney disease in blacks linked to genes on two chromosomes

November 14, 2003

WINSTON-SALEM, N.C. - As yet unidentified genes on chromosomes 18 and 3 are linked to severe kidney disease in younger blacks with diabetes, Barry I. Freedman, M.D., reported today at the American Society of Nephrology meeting in San Diego. Freedman, professor and head of the Section on Nephrology at Wake Forest University Baptist Medical Center, said blacks with these genes develop end-stage kidney disease at a much younger age. People with end-stage kidney disease require either regular dialysis or a kidney transplant to survive.

"This is the only report of this type in African-Americans," said Friedman, adding that the genes causing diabetic kidney disease may be the same as those found in some other ethic groups.

Freedman and a team that included eight other Wake Forest investigators studied 171 black families in which at least two siblings had developed kidney disease from type 2 diabetes; 312 individuals already had end-stage kidney disease. On average, diabetes began at age 39.

Using genome scans, the team's first set of analyses identified only weak evidence for the presence of kidney failure genes. But Freedman said that Carl D. Langefeld,. Ph.D., assistant professor of public health sciences (biostatistics) and Stephen S. Rich, Ph.D., professor of public health sciences and neurology, came up with a new way of analyzing the genetic data. "Using their novel analytic techniques allowed us to detect these regions containing kidney failure genes," he said.

The technique involved ranking 216 families by age when diabetes began and looking for linkages. Chromosome 18 emerged in the genomic study in people whose diabetes began at a younger age, while there was virtually no relationship to chromosome 18 in the older people. This indicated, they reported, that susceptibility in the younger group likely was related to the unidentified gene. Finding the region on a chromosome that is linked to a genetic defect is a major step toward identifying the gene, since it dramatically narrows the possibilities.

Freedman pointed out that other investigators already had linked the same region on chromosome 18 as harboring a susceptibility to kidney damage from type 2 diabetes in the Pima tribe of Native Americans and in Turkish families. The Pimas have long been identified as having an extraordinarily high rate of diabetes.

"This is the biggest African-American group ever studied," said Freedman. "Wake Forest has the largest existing collection of DNA from African-Americans with multiple members on dialysis or with diabetes."

Wake Forest University Baptist Medical Center is an academic health center including Wake Forest University School of Medicine and N.C. Baptist Hospital.
-end-
Contact: Robert Conn (rconn@wfubmc.edu), Karen Richardson (krchrdsn@wfubmc.edu) or Shannon Koontz(shkoontz@wfubmc.edu) at 336-716-4587.

Wake Forest Baptist Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.